Parkinson Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -16.24%
- Profit Growth -24.56%
- Ebitda 499.32%
- Net Worth 5.34%
- Total Assets -6.86%
About Parkinson Pharmaceuticals
Parkinson Pharmaceuticals Private Limited (PPPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 March 2012 and has a history of 12 years and 11 months. Its registered office is in Chandigarh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sandeep Bhambral and Veena Kumari serve as directors at the Company.
Company Details
-
Location
Chandigarh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74999CH2012PTC033627
-
Company No.
033627
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Mar 2012
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
What products or services does Parkinson Pharmaceuticals Private Limited offer?
Parkinson Pharmaceuticals Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops, Anti Infective Drugs & Medicines, Anti Infective Agent, Antibacterial Drugs, Digestive System Drugs & Medicines, Antacid Drugs.
Who are the key members and board of directors at Parkinson Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandeep Bhambral
|
Director | 12-Mar-2012 | Current |
|
Veena Kumari
|
Additional Director | 15-Aug-2019 | Current |
Financial Performance of Parkinson Pharmaceuticals.
Parkinson Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 16.24% decrease. The company also saw a substantial fall in profitability, with a 24.56% decrease in profit. The company's net worth moved up by a moderate rise of 5.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Parkinson Pharmaceuticals?
In 2019, Parkinson Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Parkinson Pharmaceuticals?
Unlock and access historical data on people associated with Parkinson Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Parkinson Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Parkinson Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
